Yoh, Kiyotaka
Doi, Toshihiko http://orcid.org/0000-0003-2042-6829
Ohmatsu, Hironobu
Kojima, Takashi
Takahashi, Hideaki
Zenke, Yoshitaka
Wacheck, Volker
Enatsu, Sotaro
Nakamura, Takashi
Turner, Kellie
Uenaka, Kazunori
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 14 June 2016
Accepted: 20 June 2016
First Online: 1 September 2016
Compliance with ethical standards
:
: This study was sponsored by Eli Lilly and Company, manufacturer/licensee of LY2875358. Medical writing assistance was provided by Justine Southby, PhD CMPP, and Luke Carey, PhD, of ProScribe – Envision Pharma Group, and was funded by Eli Lilly Japan K.K. ProScribe’s services complied with international guidelines for Good Publication Practice (GPP2).
: SE, TN, and KU are employees of Eli Lilly Japan K.K., and VW and KT are employees of Eli Lilly and Company. VW, SE, KT, and KU have stock/equity ownership in Eli Lilly and Company. KY and TD have received research funding from Eli Lilly and Company. HO, TK, HT, and YZ have no conflicts of interest to declare.
: All procedures performed in human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.